| dc.contributor.author | Sashidhara, K V | |
| dc.contributor.author | Singh, S P | |
| dc.contributor.author | Varshney, Salil | |
| dc.contributor.author | Beg, Muheeb | |
| dc.contributor.author | Gaikwad, A N | |
| dc.date.accessioned | 2017-05-30T07:37:21Z | |
| dc.date.available | 2017-05-30T07:37:21Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | European Journal of Medicinal Chemistry, 2014, 86, 570-7 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/1692 | |
| dc.description.abstract | In our efforts to develop safe and active chemical entities from nature, we first identified poliothrysoside (1), a phytoconstituent isolated from Flacourtia indica, possessing antidiabetic potential. Subsequently, fifteen derivatives (2-16) were synthesized to assess the activity profile of this class. All the compounds were analyzed for their glucose uptake potency in chronic insulin-induced insulin resistant 3T3-L1 adipocytes. Interestingly, compound 2 exhibited strong ability to increase the insulin sensitivity, primarily activating the AMPK signaling pathway and also inhibited the adipogenesis in 3T3-L1 adipocytes, in concentration dependent manner. Overall, these studies suggest the potential of poliothrysoside and its derivatives as promising leads for non-insulin dependent type 2 diabetes (T2D). | en |
| dc.format.extent | 493855 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | CSIR-CDRI communication no. 8757. | en |
| dc.subject | Poliothrysoside | en |
| dc.subject | Insulin resistance | en |
| dc.subject | 3T3-L1 adipocytes | en |
| dc.subject | AMPK | en |
| dc.subject | Non-insulin dependent type 2 diabetes | en |
| dc.title | Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis | en |
| dc.type | Article | en |